Soluble epoxide hydrolase inhibitors are primarily used in medical research and therapeutic applications due to their ability to modulate inflammation and pain. These inhibitors work by preventing the breakdown of epoxyeicosatrienoic acids (EETs), which are known to have anti-inflammatory, vasodilatory, and cardio-protective effects. This makes them valuable in the treatment of cardiovascular diseases, as they help reduce blood pressure and improve vascular health. Additionally, they are being explored for their potential in managing chronic pain conditions, such as neuropathic pain, by reducing inflammation in the nervous system. Research is also ongoing into their role in treating metabolic disorders, including diabetes, due to their ability to improve insulin sensitivity and reduce inflammation in adipose tissue. Furthermore, these inhibitors show promise in neurological conditions like stroke and Alzheimer's disease, where they may help protect neurons and reduce neuroinflammation.